Global End Stage Renal Disease Market

Dublin, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The "Global End Stage Renal Disease Market Size, Share & Trends Analysis Report by Treatment (Transplant, Dialysis), by Region (APAC, North America, MEA, Europe, Latin America), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering. The global end stage renal disease market size is anticipated to reach USD 261.64 billion by 2030, registering a CAGR of 12.9% over the forecast period.

Increasing number of patients suffering from kidney failure, rapid increase in the volume of hospitals & urgent care centers, and growing hospital admission rates are among the few factors propelling the market growth. Chronic Kidney Disease (CKD) is one of the major causes of increasing kidney failure rates among patients. According to the CDC, it is estimated that more than 37 million people in the U.S. suffer from CKD, whereas globally more than 500 million people (12-18% of the world population) are affected.

As a result, increasing the demand for dialysis or kidney transplant. The COVID-19 pandemic has impacted the healthcare industry and people suffering from ESRD are at a higher risk of contracting this virus, as they have to visit the hospitals often for dialysis. Center-based hemodialysis is the main renal replacement medium in most countries, with almost 90% of the ESRD population opting for it. Hemodialysis patients have to stay in hospitals for 4 hours minimum, 3 times a week, and come in frequent contact with the medical staff and other patients.

All these factors increase their risk of infection. Technological advancements in the treatment of renal failure are another factor expediting the market growth for ESRD. For instance, the innovation of Wearable Artificial Kidney (WAK) technologies, a portable dialysis device designed to enable patients to live a healthier life as it controls blood pressure, improves clearance of wastes from the blood, and allows ESRD or CKD patients to a less strict diet, and results in lower fluid weight gain in addition to lowered stress on the heart.

Thus, technical advancements in WAK have the potential to reduce mortality in dialysis patients, which thereby improves an ESRD patient's quality of life. The WAK prototypes designed and patented by innovative firms have been approved for human clinical trials by the U.S. FDA in 2016. End Stage Renal Disease Market Report Highlights

The dialysis segment dominated the global ESRD market in 2021 owing to its ease of use and emergency convenience.

this segment is further sub-segmented into peritoneal, hemodialysis, and wearable artificial kidney.

The Asia Pacific region dominated the market with the highest revenue share in 2021 and will expand further at the fastest CAGR from 2022 to 2030.

This growth can be attributed to the large population of patients with CKD/ESRD, and the greater incidence of hypertension and diabetes in the continent.

Key Topics Covered: Chapter 1. Methodology and Scope Chapter 2. Executive Summary Chapter 3. End Stage Renal Disease Market Variables, Trends & Scope 3.1 Market Lineage Outlook 3.1.1 Parent Market Outlook 3.1.2 Ancillary Market Outlook 3.2 Penetration & Growth Prospect Mapping 3.3 Product Pipeline Analysis 3.4 User Perspective Analysis 3.4.1 Consumer Behavior Analysis 3.4.2 Market Influencer Analysis 3.5 List Of Key End Users 3.6 Regulatory Framework 3.7 Market Dynamics 3.7.1 Market Driver Analysis 3.7.1.1 Growing Prevalence Of Diabetes And Hypertension 3.7.1.2 Introduction Of Technologically Advanced Products 3.7.1.3 Increasing Number Of Patients Suffering From Chronic Kidney Disease 3.7.2 Market Restraints Analysis 3.7.2.1 Risk Of Complications 3.7.2.2 Stringent Regulatory Policies For Dialysis Products 3.8 End Stage Renal Disease: Market Analysis Tools 3.8.1 Industry Analysis-Porter's 3.8.2 Swot Analysis, By Pest Chapter 4. End Stage Renal Disease Market: Segment Analysis, By Treatment, 2018-2030 (USD Million) 4.1 Definition and Scope 4.2 Treatment Market Share Analysis, 2021 & 2030 4.3 Segment Dashboard 4.4 Global End Stage Renal Disease Market, by Treatment, 2018 to 2030 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 4.5.1 DIALYSIS 4.5.1.1 Dialysis market, 2018-2030 (USD Million) 4.5.2 TRANSPLANT 4.5.2.1 Transplant market, 2018-2030 (USD Million) Chapter 5. End Stage Renal Disease Market: Regional Market Analysis, By Treatment, 2018-2030 (USD Million) Chapter 6. End Stage Renal Disease Market-Competitive Analysis 6.1 Recent Developments & Impact Analysis, by Key Market Participants 6.1.1 Nipro Corporation 6.2 Company Categorization 6.2.1 Innovators 6.2.2 Market Leaders 6.3 Vendor Landscape 6.3.1 Key Customers 6.3.2 Key Company Market Share Analysis, 2021 6.3.3 Major Deals And Strategic Alliances 6.3.3.1 New Product Launch 6.3.3.2 Expansion 6.3.3.3 Acquisition 6.3.3.4 Marketing & Promotions 6.3.4 Market Entry Strategies 6.4 Public Companies 6.4.1 Company Market Position Analysis 6.4.2 Competitive Dashboard Analysis 6.4.2.1 Market Differentiators 6.5 Private Companies 6.5.1 List of Key Emerging Companies 6.5.2 Regional Network Map 6.5.3 Company Market Position Analysis 6.6 Company Profiles 6.6.1 Medtronic 6.6.1.1 Company Overview 6.6.1.2 Financial Performance 6.6.1.3 Product Benchmarking 6.6.1.4 Strategic Initiatives 6.6.2 Fresenius Medical Care AG & Co. KGaA 6.6.2.1 Company Overview 6.6.2.2 Financial Performance 6.6.2.3 Product/Service Benchmarking 6.6.2.4 Strategic Initiatives 6.6.3 B. Braun Melsungen AG 6.6.3.1 Company Overview 6.6.3.2 Financial Performance 6.6.3.3 Product/Service Benchmarking 6.6.4 Baxter International, Inc. 6.6.4.1 Company Overview 6.6.4.2 Financial Performance 6.6.4.3 Product Benchmarking 6.6.4.4 Strategic Initiatives 6.6.5 Asahi Kasei Medical Co., Ltd. 6.6.5.1 Company Overview 6.6.5.2 Financial Performance 6.6.5.3 Product Benchmarking 6.6.5.4 Strategic Initiatives 6.6.6 Cantel Medical 6.6.6.1 Company Overview 6.6.6.2 Financial Performance 6.6.6.3 Product Benchmarking 6.6.6.4 Strategic Initiatives 6.6.7 BD 6.6.7.1 Company Overview 6.6.7.2 Financial Performance 7.6.7.3 Product Benchmarking 6.6.7.4 Strategic Initiatives 6.6.8 Nikkiso Co., Ltd. 6.6.8.1 Company Overview 6.6.8.2 Financial Performance 6.6.8.3 Product Benchmarking 6.6.8.4 Strategic Initiatives 6.6.9 JMS Co. Ltd. 6.6.9.1 Company Overview 6.6.9.2 Financial Performance 6.6.9.3 Product Benchmarking 6.6.9.4 Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/4j55lx

Global End Stage Renal Disease Market

On Wednesday, the Fed bumped up interest rates again, its third 75-basis point hike since June, and signaled that there could be two more such hikes by the end of this year. The conventional wisdom has the Fed acting properly, and aggressively, in an attempt to counter inflation raging at 40-year high levels. But conventional wisdom isn’t always right – and we can learn a lot by consulting the contrarians. Few top investors are more contrarian than Cathie Wood. The founder and manager of ARK Inv

Homeowners beware. But don't panic, either.

In this article, we will look at the 4 stocks billionaire Leon Cooperman is talking about right now. If you want to skip reading about Leon Cooperman, his investment career, and his stock-picking strategy, you can go directly to Billionaire Leon Cooperman is Talking About These 2 Stocks. Leon Cooperman’s Investment Career Leon Cooperman is […]

And what it means for your wealth-building options.

You have just a few weeks to pounce on Treasury I bonds' sky-high interest rate. Also called Series I savings bonds, their interest rate is 9.62%.

The shipping company has developed a reputation as one of the best dividend stocks around

Yahoo Finance Live anchor Seana Smith highlights stocks moving in after-hours trading, including Ford, FedEx, and Moderna.

Boeing (NYSE: BA) made a big move to put part of its troubled past behind it, but the aerospace manufacturer also apparently has fallen out of favor with what had been a key customer in China. Boeing has taken its investors on a turbulent ride over the past few years. The company's 737 MAX, which was once billed as having the potential to be the top-selling aircraft of all time, was involved in fatal crashes in 2018 and 2019 that led to the plane being grounded for 18 months and prompted a comprehensive review of Boeing's engineering and safety practices.

In this article, we discuss the 11 best commodity stocks to invest in. If you want to read about some more commodity stocks, go directly to 5 Best Commodity Stocks To Invest In. Macroeconomic concerns have been clouding the commodities market in the past few days after the Federal Reserve in the United States hiked […]

Forget everything you think you know about the relationship between interest rates and the stock market.

Netflix Inc. is seeking a new chief accounting officer after its current one quit the role after less than four months.

UBS's Colin Bristow raised his rating on the stock to Buy from Neutral, saying Well Street's expectations for sales of Mounjaro are too low.

Yahoo Finance's Jared Blikre joins the Live show to check out market and sector losses amid today's sell-off, while also looking at meme stocks and the travel industrial.

(Bloomberg) -- Russia’s wheat harvest could reach a historic 100 million tons, according to consultant SovEcon, with the commodity piling up at home as the nation struggles to export large volumes.Most Read from BloombergBank of England Says Paper Banknotes Only Good for One More WeekJapan to Restore Visa-Free Travel From Oct. 11 as Covid Pandemic Recedes South Korea President Caught on Hot Mic Insulting US CongressUnless Rents Rise, Housing Is Set Up for an Epic CrashA Great Copper Squeeze Is C

At a companywide all-hands meeting this week, Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) chief Sundar Pichai juggled tough questions from employees regarding cuts to travel and entertainment budgets, managing productivity, and potential layoffs. Employees questioned why Google is "nickel-and-diming employees" by cutting travel and swag budgets despite record profits and substantial cash reserves as it did after the pandemic. Pichai emphasized acting responsibly to tide through such critical sit

As much as stocks are falling, moves in another financial market have even more profound implications for the global economy.

The market has soured on these stocks, but insiders are buying. Is it time to load up on these companies?

AT&T Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $T performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.Check out the ticker page here.

Needless to say, this has investors -- especially those looking for dividends -- very interested in energy stocks right now. Two in particular are getting a lot of attention: Chevron (NYSE: CVX) and Enterprise Products Partners (NYSE: EPD). While both Chevron and Enterprise Products are strong companies (I own Enterprise Products, too), there are some characteristics of Phillips 66 that are very compelling.

Shares of recreational vehicle (RV) company Camping World Holdings (NYSE: CWH) crashed on Friday, after an analyst lowered their price target in a research note. As of 1:10 p.m. ET, Camping World stock was down 10%. Truist analyst Michael Swartz has been busily researching the state of the RV market, which led him to lower his target price for Camping World stock.